<html>
<head>PUBMED IDs for p120GAP</head>
<body bgcolor='#C5F0F2'><h1>p120GAP</h1><a href='https://pubmed.ncbi.nlm.nih.gov/1568246/'>Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.</a> April 17  1992<br><a href='https://pubmed.ncbi.nlm.nih.gov/8335107/'>Differential contribution of M(r) 120 kDa rasGTPase-activating protein and neurofibromatosis type 1 gene product during the transition from growth phase to arrested state in human fibroblasts accompanied by a unique rasGTPase-activating activity.</a> July 26  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/8166672/'>Ras regulatory interactions: novel targets for anti-cancer intervention?</a> March 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/8195713/'>Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.</a> June 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/8051149/'>Identification of a human rasGAP-related protein containing calmodulin-binding motifs.</a> August 12  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/9668168/'>Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.</a> July 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9687500/'>Structural analysis of the GAP-related domain from neurofibromin and its implications.</a> August 4  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9778042/'>Sulindac sulfide inhibits Ras signaling.</a> October 20  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/11080503/'>Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.</a> November 18  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11566491/'>Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras.</a> September 22  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12367560/'>Constitutive up-regulated activity of MAP kinase is associated with down-regulated early p21Ras pathway in lymphocytes of SLE patients.</a> October 9  2002<br></body></html>
